Violation Tracker Parent Company Summary

Parent Company Name: 
Allergan
Ownership Structure: 
publicly traded (ticker symbol AGN)
Headquartered in: 
Ireland (reincorporated for tax reasons)
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$1,297,622,288
Number of records: 
31
Top 10 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$889,000,0004
False Claims Act and related$343,770,91418
price-fixing or anti-competitive practices$45,500,0002
investor protection violation$15,000,0001
employment discrimination$4,000,0001
environmental violation$150,8003
Medicare Coverage Gap Discount Program violation$116,7031
wage and hour violation$83,8711
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

ACTAVIS; ACTAVIS KADIAN; ALLERGAN; Andrx Corporation; Forest Laboratories; FOREST LABS AND FOREST PHARMACEUTICALS; Forest Pharmaceuticals Inc.; VALMED PHARMACEUTICAL; Warner Chilcott Holdings; WARNER CHILCOTT PLC; WATSON LABS; Watson Pharmaceuticals Inc. and Watson Pharma Inc.; Watson Pharmaceuticals, Inc.; Watson, Inc.; Watson/Schein Pharmaceuticals Inc.

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Allergan Inc. off-label or unapproved promotion of medical products 2010 FDA $600,000,000
Forest Pharmaceuticals Inc. off-label or unapproved promotion of medical products 2011 FDA $164,000,000
Forest Pharmaceuticals Inc. False Claims Act and related 2010 USAO $149,000,000
Warner Chilcott PLC off-label or unapproved promotion of medical products 2015 FDA $125,000,000
Watson Pharmaceuticals False Claims Act and related 2011 MULTI-AG $70,000,000
Forest Pharmaceuticals Inc. False Claims Act and related 2010 MULTI-AG (*) $60,000,000
Andrx Corporation price-fixing or anti-competitive practices 2003 MULTI-AG $40,000,000
Forest Laboratories and Forest Pharmaceuticals False Claims Act and related 2016 DOJ_CIVIL $38,000,000
Watson, Inc. False Claims Act and related 2018 MS-AG $33,408,547
Allergan Inc. investor protection violation 2017 SEC $15,000,000
Forest Laboratories False Claims Act and related 2009 AL-AG $14,833,333
Allergan Inc. off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $14,750,000
Watson/Schein Pharmaceuticals Inc. False Claims Act and related 2011 TX-AG $11,300,000
Warner Chilcott PLC False Claims Act and related 2015 MULTI-AG (*) $10,600,000
Forest Laboratories Inc. False Claims Act and related 2019 IL-AG $7,089,034
Warner Chilcott Holdings price-fixing or anti-competitive practices 2007 MULTI-AG $5,500,000
Forest Laboratories, Inc. employment discrimination 2018 private lawsuit-federal $4,000,000
Actavis False Claims Act and related 2012 LA-AG $4,000,000
Allergan Inc. False Claims Act and related 2018 USAO $3,500,000
Forest Laboratories False Claims Act and related 2013 LA-AG $3,000,000
Forest Laboratories False Claims Act and related 2013 TX-AG $3,000,000
Forest Laboratories LLC False Claims Act and related 2016 MULTI-AG (*) $2,500,000
Watson Pharmaceuticals, Inc. False Claims Act and related 2010 MA-AG $2,400,000
Forest Pharmaceuticals Inc. False Claims Act and related 2012 KY-AG $1,750,000
Watson Pharmaceuticals Inc. and Watson Pharma Inc. False Claims Act and related 2012 ID-AG $1,700,000
Forest Laboratories, Inc. False Claims Act and related 2012 ID-AG $790,000
Actavis Kadian, LLC Medicare Coverage Gap Discount Program violation 2013 CMS $116,703
STEEL FOREST LLC environmental violation 2005 EPA $100,000
Valmed Pharmaceutical, Inc. wage and hour violation 2004 WHD $83,871
ACTAVIS,INC. environmental violation 2015 EPA $30,800
Watson Laboratories, Inc. environmental violation 2004 EPA $20,000
Download results as CSV or XML